September 1st 2020
By Skylar Jeremias
A look at efforts biosimilar manufacturers are taking to develop treatments for coronavirus disease 2019 (COVID-19).
August 31st 2020
By Deana Ferreri, PhD
Health technology tssessments play an important role in building confidence for use of biosimilars, yet very few meet criteria for thoroughness.
August 29th 2020
By Tony Hagen
With the launch of an adalimumab, Cadila hopes to get a piece of the worldwide biosimilar market for antirheumatic treatments.
August 25th 2020
The statistics show that for the Rocky Mountain province, biosimilar savings are pouring into the health care system and allowing for significantly greater access.
August 24th 2020
From China to Taiwan, BeiGene and Bio-Thera Solutions hope to capture a large share of the bevacizumab biosimilar market.
August 21st 2020
Express Scripts, the country's largest pharmacy benefit manager, has reshuffled its preferred formulary list for 2021, giving preference to fewer pegfilgrastim products than in 2020.
August 20th 2020
Samsung Bioepis' latest approval gives it 5 biosimilar approvals in the European marketplace.
August 19th 2020
After receiving regulatory approval in June, Sandoz launched 2 of its biosimilars on the Canadian market.
August 18th 2020
By The Center for Biosimilars
Ali Mcbride, PharmD, MS, BCOP, is taking a lead role in promoting the use and understanding of biosimilars in oncology.
August 17th 2020
A Pacific Research Institute economist says that by his scorecard, biosimilars are not supercharging the market the way they ought to be doing .
